** Drugmaker Cidara Therapeutics' shares rise 20.9% to $18.28
** CDTX raises $105 mln in private placement, co says
** Co says Venrock Healthcare Capital Partners and other life sciences-focused investors will purchase ~3.9 mln shares of CDTX at $14.912 per share
** Co also says certain investors will buy pre-funded warrants that would allow them to buy ~3.1 mln shares of CDTX at $14.9119 per share
** CDTX says it intends to use the funds for research and development, working capital and general corporate purposes
** All 5 brokerages rate the stock "buy" or higher; their median PT is $29 - LSEG
** Including session's gains, stock has risen 13.5% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。